by PRI | Jun 20, 2022 | Microbiome Product Developer
Tomas de Wouters Co-Founder & CEO Pioneering the development of microbiome-based therapies using proprietary tools for their design and production....
by PRI | Jun 20, 2022 | Pharma (Veterinary)
Mirja Huhtinen Director, Animal Health R&D Orion Pharma Animal Health R&D develops innovative medicinal, ProHealth and microbiome products to global markets. Our flagship microbiome product is Broilact....
by PRI | Jun 20, 2022 | Investment | Incubator | Accelerator | Tech Transfer
Stanislas Desjonquères CEO We transform academic therapeutic and microbiome-based projects into products for Humans. Our value is to source, fund and operate these projects....
by PRI | Jun 20, 2022 | Pharma (Human)
Laurent Ameye Global Regulatory Compliance Manager Our expertise areas includes food supplements, medical nutrition, and pharmaceutical solutions on areas including food allergies, metabolic/gastrointestinal health, healthy aging and adult acute care....
by PRI | Jun 20, 2022 | Microbiome Product Developer
Katja Conrath Chief Scientific Officer Unlocking the full potential of the gut microbiome for development of effective therapeutics through our proprietary CORAL™ consortia optimization and single-process manufacturing technology....
